HopeStage
Back to all studies
RecruitingNCT07247968

Esketamine with electroconvulsive therapy for severe depression in adolescents

About this titleRead the official source — NCT07247968
Medication studyAges 13–17China
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: 13 years to 17 years. Other eligibility criteria apply.

Listed locations
Chongqing and 1 more locationSee all locations and recruitment
Study phase
Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: November 25, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
220
Sponsor
Min Su
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug, Other
Study phase
Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
China
Age range
From 13 Years to 17 Years
Official registry ID
NCT07247968
Official title
Show the full official title

Clinical and Mechanistic Study of Subanesthetic-dose Esketamine in Modified Electroconvulsive Therapy for Adolescents With Severe Depression

Recruitment & locations

Currently recruiting

Chongqing

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Min Su.

Does this study involve medication?

Yes. The study involves medication, including Esketamine injection group (0.25 mg/kg).

Who can participate?

This study is for people with depression. Listed age limits: 13 years to 17 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies